Updated June 27 at 12:27pm
Biotechnology
34 results total, viewing 1 - 10
More than $480,000 has been awarded by the Rhode Island Foundation in seed funding for 20 medical research projects. more
Alexion Pharmaceuticals Inc. fell the most in six years after the company’s drug for a rare neuromuscular disease failed to meet its primary goal in a final-stage trial. more
A five-year, $11.5 million grant from the National Institutes of Health will allow Brown University to launch the Center for Biomedical Research Excellence to study cancer, preeclampsia and severe lung infections. more
Richard A. Andrews has been appointed chief operating officer at ProThera Biologics. more
Medtronic PLC, the largest maker of equipment to treat spinal conditions, agreed to help promote Mazor Robotics Ltd.’s guidance system used during spinal surgeries and will take an equity stake of up to 15 percent in the company. Mazor’s stock surged. more
Rhode Island ranked 33rd in the nation for venture-capital investment in the first quarter, which featured only one deal - $5 million to IlluminOss Medical Inc. more
(Updated 9:57 a.m. and 1:43 p.m.) Nabsys has completed a financial restructuring and is back in business, operating out of its Clifford Street office. more
Medtronic PLC plans to consolidate its operations in Mansfield. Company spokesman Fernando Vivanco said Medtronic will consolidate its buildings from four to three. more
After sitting out for most of the biotech acquisition frenzy of 2015, Amgen Inc. is ready to do a deal. more
1 | 2 | 3 | 4 Next »